EGF and non-small cell lung carcinoma: Given the low access to ICIs, the current standard for advanced NSCLC in Cuba for patients without actionable mutations and EGF concentration above 870 pg/ml consists of platinum doublets followed by switch maintenance with CIMavax-EGF.